These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33455997)
1. Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque. Egusa G J Atheroscler Thromb; 2021 Oct; 28(10):1020-1022. PubMed ID: 33455997 [No Abstract] [Full Text] [Related]
2. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events. Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease. Soto Y; Conde H; Aroche R; Brito V; Luaces P; Nasiff A; Obregón A; Vázquez López AM Hum Antibodies; 2009; 18(3):109-17. PubMed ID: 19729805 [TBL] [Abstract][Full Text] [Related]
4. Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina. Yoshinaga M; Yuasa E; Matsuoka T; Kihara S; Yamamoto H J Atheroscler Thromb; 2024 Jul; 31(7):1087-1097. PubMed ID: 38325861 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease. McDowell A; Young IS; Wisdom GB J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895 [TBL] [Abstract][Full Text] [Related]
7. Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque. Imai M; Kawamura M; Kochi I; Matsuoka T; Kihara S; Yamamoto H J Atheroscler Thromb; 2021 Oct; 28(10):1025-1034. PubMed ID: 33191364 [TBL] [Abstract][Full Text] [Related]
8. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466 [TBL] [Abstract][Full Text] [Related]
9. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice. Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775 [TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis]. Afanasievа OI; Pylaeva EA; Klesareva EA; Potekhina AV; Provatorov SI; Afanasieva MI; Krasnikova TL; Masenko VP; Arefieva TI; Pokrovsky SN Ter Arkh; 2016; 88(9):31-38. PubMed ID: 27735911 [TBL] [Abstract][Full Text] [Related]
11. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome. Laczik R; Szodoray P; Veres K; Szomják E; Csípo I; Sipka S; Shoenfeld Y; Szekanecz Z; Soltész P Lupus; 2011 Jun; 20(7):730-5. PubMed ID: 21505011 [TBL] [Abstract][Full Text] [Related]
12. Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease. Kothari H; Nguyen AT; Yang X; Hisada Y; Tsimikas S; Mackman N; Taylor A; McNamara CA J Cardiovasc Transl Res; 2018 Jun; 11(3):221-229. PubMed ID: 29344841 [TBL] [Abstract][Full Text] [Related]